MyAverix Finance
SHG · Healthcare
North China Pharmaceutical Co Ltd (600812)
Drug Manufacturers - Specialty & Generic
North China Pharmaceutical Co Ltd (600812) is listed on SHG in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-28, reported market cap is $9.14B, P/E ratio is 48.45, net margin is 1.9%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 600812
North China Pharmaceutical Co Ltd (600812) — FAQ
What is North China Pharmaceutical Co Ltd's market cap?
North China Pharmaceutical Co Ltd (600812) has a reported market cap of $9.14B (data as of 2026-03-28).
What is 600812's P/E ratio?
The price-to-earnings (P/E) ratio for North China Pharmaceutical Co Ltd (600812) is 48.45 (data as of 2026-03-28).
Does North China Pharmaceutical Co Ltd pay a dividend?
Dividend yield is not available in the current snapshot for North China Pharmaceutical Co Ltd (600812). Check the MyAverix Finance app for the latest dividend data.
What sector is North China Pharmaceutical Co Ltd in?
North China Pharmaceutical Co Ltd (600812) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is 600812 listed on?
600812 is listed on SHG.
What is North China Pharmaceutical Co Ltd's net margin?
North China Pharmaceutical Co Ltd (600812) reports a net margin of 1.9% (data as of 2026-03-28).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.